Suppr超能文献

代谢相关脂肪性肝病患者健康生活方式与全因死亡率的相关性。

Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease.

机构信息

Department of Epidemiology & Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Beijing 100191, China.

出版信息

Nutrients. 2022 Oct 11;14(20):4222. doi: 10.3390/nu14204222.

Abstract

BACKGROUND AND AIMS

There is limited evidence about the association of healthy lifestyle and all-cause mortality in individuals with metabolic associated fatty liver disease (MAFLD). We aimed to examine this association and compare it with the association in those without MAFLD.

METHODS

A prospective cohort study was performed and linked mortality data through 2019 in the National Health Nutrition Examination Survey (NHANES 1999-2010). A healthy lifestyle score was constructed from cigarette smoking, alcohol drinking, healthy eating score, and leisure-time physical activity. Risk stratification was conducted in participants with MAFLD by fibrosis biomarkers and liver enzymes. Survey-weight adjusted Cox regression was used to estimate adjusted hazard ratios (HRs) and confidence intervals (CIs) for all-cause mortality associated with healthy lifestyle.

RESULTS

There was a protective association between healthy lifestyle and all-cause mortality in participants with MAFLD (HR per 1-unit increase of healthy lifestyle score 0.77 [95% CI 0.69-0.85]), with no difference from the association in participants without MAFLD (HR 0.77 [0.72-0.82]). In participants with MAFLD, the associations tended to be stronger in those with lower risk of advanced fibrosis (HR per 1-unit increase of healthy lifestyle score 0.64 [0.50-0.79] for low NAFLD fibrosis score [NFS] and 0.84 [0.75-0.93] for high NFS, -value for interaction 0.02), but did not differ by liver enzymes. The results for non-alcoholic fatty liver disease (NAFLD) mirrored those for MAFLD.

CONCLUSIONS

Healthy lifestyle showed protective associations with all-cause mortality regardless of MAFLD status, and the associations tended to be stronger in those with lower risk of advanced fibrosis. Timely lifestyle modification matters for individuals with MAFLD.

摘要

背景和目的

代谢相关脂肪性肝病(MAFLD)患者的健康生活方式与全因死亡率之间的关联证据有限。本研究旨在检验这种关联,并与非 MAFLD 患者进行比较。

方法

本研究进行了一项前瞻性队列研究,并通过 2019 年国家健康营养调查(NHANES 1999-2010)链接了死亡率数据。健康生活方式评分由吸烟、饮酒、健康饮食评分和休闲时间体力活动构成。通过纤维化生物标志物和肝酶对 MAFLD 患者进行风险分层。采用调查权重调整的 Cox 回归估计与健康生活方式相关的全因死亡率的调整后危险比(HR)和置信区间(CI)。

结果

在 MAFLD 患者中,健康生活方式与全因死亡率之间存在保护关联(健康生活方式评分每增加 1 个单位,HR 为 0.77 [95%CI 0.69-0.85]),与非 MAFLD 患者的关联无差异(HR 0.77 [0.72-0.82])。在 MAFLD 患者中,这种关联在纤维化风险较低的患者中似乎更强(低 NAFLD 纤维化评分(NFS)时,健康生活方式评分每增加 1 个单位的 HR 为 0.64 [0.50-0.79],高 NFS 时为 0.84 [0.75-0.93],交互检验值为 0.02),但与肝酶无关。非酒精性脂肪性肝病(NAFLD)的结果与 MAFLD 相似。

结论

健康的生活方式与全因死亡率呈保护关联,与 MAFLD 状态无关,且在纤维化风险较低的患者中关联更强。及时进行生活方式改变对 MAFLD 患者很重要。

相似文献

本文引用的文献

3
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis.2019 年全球非酒精性脂肪性肝病患病率:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2809-2817.e28. doi: 10.1016/j.cgh.2021.12.002. Epub 2021 Dec 7.
5
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验